Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2024

Jun 24, 2024

31996_dirs_2024-06-24_6749e6a7-f54b-41ea-bb1d-a5750e24e959.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2024-06-20

Reporting Person: Jiang Wei (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-20 Common Stock A 2244 $0.00 Acquired 3543 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-20 Common Stock Options $40.11 A 4010 Acquired 2034-06-19 Common Stock (4010) Direct

Footnotes

F1: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders.